Date published: 2026-1-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

C3orf34_1500031L02Rik Activators

C3orf34_1500031L02Rik activators are a class of chemical compounds designed to enhance the activity of the protein encoded by the C3orf34 gene in humans, or its ortholog 1500031L02Rik in mice. Unlike inhibitors, which aim to reduce or halt the function of a protein, activators work to increase its action within biological pathways. The mode of action of such activators may involve stabilizing the protein in an active conformation, enhancing its ability to interact with other biomolecules, or increasing its overall expression levels within the cell. The development of these activators requires an in-depth understanding of the protein's structure, the conformational states it undergoes during its functional cycle, and the regulatory mechanisms that control its activity. Chemical activators are often engineered to interact with regions of the protein that are critical for its activation, such as allosteric sites, which are distinct from the active site but can influence the protein's activity when bound by an effector molecule.

Activators of the C3orf34_1500031L02Rik protein are thus important tools in cellular and molecular research. By artificially modulating the activity of the protein, scientists can investigate the downstream effects in various biochemical pathways and gain insights into the protein's role within these processes. The design of such molecules can be complex, requiring iterative cycles of synthesis and testing to identify compounds that are both effective and specific in their action. Advanced techniques in computational chemistry may be used to model interactions between potential activators and the protein at the atomic level, predicting which compounds are most likely to have the desired effect on protein function. Once identified, these activators can be employed in experimental studies, allowing researchers to dissect the biological function of the C3orf34_1500031L02Rik protein, study its interactions with other cellular components, and understand how it contributes to the regulation of cellular processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

A microtubule-stabilizing agent that promotes tubulin polymerization, potentially supporting microtubule structures required for CEP19 function in centrosome and ciliary base.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

A microtubule-destabilizing agent that, at low concentrations, can stimulate microtubule dynamics, indirectly affecting CEP19's role in microtubule anchoring.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

An inhibitor of GSK-3β, which might influence microtubule dynamics and vesicle trafficking, indirectly affecting CEP19's associated pathways.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

A ROCK inhibitor that can modulate actin cytoskeleton dynamics, potentially impacting microtubule stability and thus CEP19's function in ciliogenesis.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$137.00
$512.00
7
(1)

A Cdc42 GTPase inhibitor that, through modulating GTPase activity, could have downstream effects on microtubule organization and ciliary function linked to CEP19.

ZCL278

587841-73-4sc-507369
10 mg
$115.00
(0)

A Cdc42 GTPase inhibitor that might alter vesicle trafficking and microtubule dynamics, indirectly affecting CEP19's function in ciliogenesis.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$151.00
$609.00
75
(4)

A Rac1 inhibitor that indirectly impacts actin dynamics and possibly microtubule stability, potentially influencing CEP19's role in cilia formation.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

An inhibitor of actin polymerization that can alter cytoskeletal organization, potentially affecting vesicular processes and ciliary assembly involving CEP19.